BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 11654797)

  • 1. Molecular politics in a global economy.
    Wright S
    Politics Life Sci; 1996 Sep; 15(2):249-63. PubMed ID: 11654797
    [No Abstract]   [Full Text] [Related]  

  • 2. The social warp of science: writing the history of genetic engineering policy.
    Wright S
    Sci Technol Human Values; 1993; 18(1):79-101. PubMed ID: 11652076
    [No Abstract]   [Full Text] [Related]  

  • 3. Molecular biology or molecular politics? The production of scientific consensus on the hazards of recombinant DNA technology.
    Wright S
    Soc Stud Sci; 1986 Nov; 16(4):593-620. PubMed ID: 11650809
    [No Abstract]   [Full Text] [Related]  

  • 4. From Asilomar to industrial biotechnology: risks, reductionism and regulation.
    Krimsky S
    Sci Cult (Lond); 2005 Dec; 14(4):309-23. PubMed ID: 16619467
    [No Abstract]   [Full Text] [Related]  

  • 5. Recombinant DNA and the regulation of biotechnology: reflections on the Asilomar Conference, ten years after.
    Barkstrom JE
    Akron Law Rev; 1985; 19(1):81-126. PubMed ID: 11650740
    [No Abstract]   [Full Text] [Related]  

  • 6. Coordinated framework for regulation of biotechnology; announcement of policy; notice for public comment.
    U.S. Office of Science and Technology Policy
    Fed Regist; 1986 Jun; 51(123):23302-50. PubMed ID: 11655807
    [No Abstract]   [Full Text] [Related]  

  • 7. Coordinated framework for regulation of biotechnology; establishment of the Biotechnology Science Coordinating Committee; notice.
    U.S. Office of Science and Technology Policy
    Fed Regist; 1985 Nov; 50(220):47174-95. PubMed ID: 11655733
    [No Abstract]   [Full Text] [Related]  

  • 8. Guidelines for research involving recombinant DNA molecules.
    U.S. National Institutes of Health
    Fed Regist; 1984 Nov; 49(227):46266-91. PubMed ID: 11655642
    [No Abstract]   [Full Text] [Related]  

  • 9. Proposal for a coordinated framework for regulation of biotechnology.
    U.S. Office of Science and Technology Policy
    Fed Regist; 1984 Dec; 49(252):50856-907. PubMed ID: 11655658
    [No Abstract]   [Full Text] [Related]  

  • 10. Recombinant DNA research: proposed actions under the guidelines; notice.
    U.S. National Institutes of Health
    Fed Regist; 1997 Feb; 62(31):7108-23. PubMed ID: 11654870
    [No Abstract]   [Full Text] [Related]  

  • 11. The regulation of recombinant DNA research: the alternative of local control.
    Rosenblatt DP
    Boston Coll Environ Aff Law Rev; 1982; 10(1):37-78. PubMed ID: 11649694
    [No Abstract]   [Full Text] [Related]  

  • 12. Genetic manipulation: recommendations drafted.
    Norman C
    Nature; 1975 Dec; 258(5536):561-4. PubMed ID: 11643295
    [No Abstract]   [Full Text] [Related]  

  • 13. White House to release biotechnology guidelines.
    Sun M
    Science; 1986 Jun; 232(4755):1189. PubMed ID: 11643922
    [No Abstract]   [Full Text] [Related]  

  • 14. Recombinant DNA research; actions under guidelines; notice.
    U.S. National Institutes of Health
    Fed Regist; 1987 Aug; 52(163):31848-50. PubMed ID: 11645639
    [No Abstract]   [Full Text] [Related]  

  • 15. Recombinant DNA research; actions under guidelines; notice.
    U.S. National Institutes of Health
    Fed Regist; 1984 Apr; 49(81):17844-8. PubMed ID: 11655581
    [No Abstract]   [Full Text] [Related]  

  • 16. International and European regulation of recombinant DNA research.
    Tooze J
    Univ Toledo Law Rev; 1981; 12(4):869-90. PubMed ID: 11649589
    [No Abstract]   [Full Text] [Related]  

  • 17. Guidelines for research involving recombinant DNA molecules.
    U.S. National Institutes of Health
    Fed Regist; 1983 Jun; 48(106):24556-81. PubMed ID: 11655244
    [No Abstract]   [Full Text] [Related]  

  • 18. Genetic engineering and related biotechnologies: scientific progress and public policy.
    Perpich JG
    Technol Soc; 1983; 5(1):27-49. PubMed ID: 11650684
    [No Abstract]   [Full Text] [Related]  

  • 19. Institutional biosafety committees and the inadequacies of risk regulation.
    Bereano PL
    Sci Technol Human Values; 1984; 9(4):16-34. PubMed ID: 11649608
    [No Abstract]   [Full Text] [Related]  

  • 20. Biotechnology and culture: the impact of public debates on government regulation in the United States and Denmark.
    Baark E; Jamison A
    Technol Soc; 1990; 12(1):27-44. PubMed ID: 11650912
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.